Brianna Scotland

Pharmaceutical Science

Area of Doctoral Study: Pharmaceutical Science
Undergraduate Institute: University of the Virgin Islands

Research Advisors: Ryan Pearson, Ph.D.

Description of Research

Nanoparticle-based immunotherapies offer significant potential to treat numerous diseases and can be applied to immune applications such as tolerance. My research focuses on developing biomaterials to induce robust and antigen-specific immune responses. My project aims to demonstrate that bioconjugate nanoparticles can be efficiently recognized by Antigen Presentation Cells (APCs) and facilitate the precise delivery of whole proteins. This would offer the opportunity to functionally tune therapeutic immune responses through modulation of nanoparticle physicochemical characteristics.